Emvododstat

N/A

Report date: 2023/01/14 20:00:39
NME

Base Information

Drug NameEmvododstat
Drug Alias NamePTC-299
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVascular endothelial growth factor A inhibitorsDihydroorotate dehydrogenase inhibitors
TargetsVascular endothelial growth factor ADihydroorotate dehydrogenase
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Metastatic breast cancerCNS Embryonal Tumor +[9] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesPoland +[11] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPtc Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPtc Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)Metastatic breast cancerCNS Embryonal Tumor +[9] 

Other Information

ATC CodeN/A
Related LinksDrugBank